| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma
|
Froehlich, Tabea C.
|
|
|
134 |
5 |
p. 445-455
|
article
|
| 2 |
Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma
|
Chari, Ajai
|
|
|
134 |
5 |
p. 421-431
|
article
|
| 3 |
Editorial Board
|
|
|
|
134 |
5 |
p. i
|
article
|
| 4 |
Epo receptor marks the spot
|
Paulson, Robert F.
|
|
|
134 |
5 |
p. 413-414
|
article
|
| 5 |
Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis
|
Muñoz-González, Javier I.
|
|
|
134 |
5 |
p. 456-468
|
article
|
| 6 |
Giant intracytoplasmic inclusions in a T-cell large granular lymphocytic leukemia patient with acute severe anemia
|
Coffy, Schnyder
|
|
|
134 |
5 |
p. 492
|
article
|
| 7 |
How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns
|
Mazepa, Marshall A.
|
|
|
134 |
5 |
p. 415-420
|
article
|
| 8 |
Identification and transcriptome analysis of erythroblastic island macrophages
|
Li, Wei
|
|
|
134 |
5 |
p. 480-491
|
article
|
| 9 |
Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population
|
Cordua, Sabrina
|
|
|
134 |
5 |
p. 469-479
|
article
|
| 10 |
ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model
|
Chiang, Chi-Ling
|
|
|
134 |
5 |
p. 432-444
|
article
|
Journal description